Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Prestige Consumer Healthcare Inc.

Stage 4 · Declining · week 4

As of Oct 22, 2026, Prestige Consumer Healthcare is in Stage 4, the downtrend phase, now in week 4 (since Sep 30, 2026). It closed at $49.46, 29.6% below its 52-week high and below its 200-day average, which is falling.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Au… More about the company

$49.46
+3.21% today
$2.3B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PBH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 17w
S2 27w
S4 24w
S4 19w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 6w → S4 10w → S1 6w → S2 17w → S3 10w → S2 27w → S3 4w → S2 9w → S3 4w → S2 6w → S3 2w → S4 24w → S1 11w → S4 19w → S1 7w → S4 3w current
Total tracked: 166 weeks across 16 stage runs.

PBH among Drug Manufacturers - Specialty & Generic41st of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…41PBHStage 4 · wk 439+7.7%
vs 52W High
-29.6%
$44.77 lo$70.21 hi
29.6% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 4
1w13w26w
Week 4, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-9.4%
200 DMA: $54.57 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.21x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+7.7%
3M
-0.4%
6M
-14.4%
YTD
-19.2%
1Y
-20.9%
Scan Membership
Breakout Watch
Latest: 2025-06-05
11 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 4 · Vol 1.21x
2026-10-21S4
Wk 4 · Vol 0.75x
2026-10-20S4
Wk 3 · Vol 0.97x
2026-10-19S4
Wk 3 · Vol 1.24x
2026-10-16S4
Wk 3 · Vol 1.05x
2026-10-15S4
Wk 3 · Vol 0.96x
2026-10-14S4
Wk 3 · Vol 1.21x
2026-10-13S4
Wk 2 · Vol 0.87x
2026-10-12S4
Wk 2 · Vol 0.73x
2026-10-09S4
Wk 2 · Vol 0.57x
2026-10-08S4
Wk 2 · Vol 0.98x
2026-10-07S4
Wk 2 · Vol 0.81x
Moving averages & range
50 DMA
$48.86
200 DMA
$54.57
52W High
$70.21
52W Low
$44.77
5D Low
$47.92
Resistance levels (recent highs)
20d High
$49.92
60d High
$54.85
120d High
$55.75
250d High
$70.21
Next resistance
+0.9%
to 20d High
P/E (TTM)
13.9
Forward 9.7
Earnings Growth (YoY)
-35.8%
Revenue +6.5%
ROE
+9.1%
Profit margin +15.6%
Dividend Yield
0.00%
P/B 1.2

Prestige Consumer Healthcare: quick answers

What stage is Prestige Consumer Healthcare in?

As of Oct 22, 2026, Prestige Consumer Healthcare (PBH) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 30, 2026 and is in week 4. What the four stages mean

Is Prestige Consumer Healthcare in an uptrend?

No. Prestige Consumer Healthcare is in a Stage 4 downtrend. It trades 9.4% below its 200-day average, which is falling.

How far is Prestige Consumer Healthcare from its 52-week high?

Prestige Consumer Healthcare closed at $49.46 on Oct 22, 2026, 29.6% below its 52-week high of $70.21. Its 52-week low is $44.77.

How has Prestige Consumer Healthcare performed over the past year?

As of Oct 22, 2026, Prestige Consumer Healthcare is down 20.9% over the past year and down 19.2% so far in 2026.

Which sector and industry is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.